Global Herpes Treatment Market Insights and Forecast to 2026

Genital herpes is a common sexually transmitted disease. With the increase in population of various regions, there is also an increase in the rate of health issues around the world. As the rate of diseases grow, the treatment markets are also expected to grow substantially. With respect to sexually transmitted disease like genital herpes, its treatment market includes different drug types like Acyclovir, Valacyclovir and Famciclovir. The indication of genital herpes include HSV-1 and HSV-2.
The rising prevalence of shingles or herpes zoster in the older population is one of the key drivers responsible for the market’s growth. According to the center for disease control and prevention (CDC), almost one in every three individuals in the US are likely to develop shingles during their lifetime. People aged 50 years and above can develop this disease due to weakened immune system. Complications associated with this disease such as post-herpetic neuralgia (PHN) can cause severe pain in the areas where the rashes occurred due to shingles. People administered with immunosuppressants in the past can also develop the disease. CDC recommends that one dose of the zoster vaccine must be prescribed to adults who are 60 years and above to reduce the probability of the disease and PHN. This will drive the demand for drugs for virus types such as herpes simplex and herpes zoster, subsequently fueling market growth.

Market Analysis and Insights: Global Herpes Treatment Market
The global Herpes Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Herpes Treatment Scope and Market Size
Herpes Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Herpes Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Herpes Treatment market is segmented into
Acyclovir
Valacyclovir
Famciclovir

Segment by Application, the Herpes Treatment market is segmented into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores

Regional and Country-level Analysis
The Herpes Treatment market is analysed and market size information is provided by regions (countries).
The key regions covered in the Herpes Treatment market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape

and Herpes Treatment Market Share Analysis
Herpes Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Herpes Treatment business, the date to enter into the Herpes Treatment market, Herpes Treatment product introduction, recent developments, etc.

The major vendors covered:
Gilead
GlaxoSmithKline
Merck
Novartis
Abbott
Mylan
Teva Pharmaceutical Industries
Vical

Frequently Asked Questions